PT2308497E - Composição farmacêutica com glicosaminoglicanos e sua utilização no tratamento das úlceras crónicas - Google Patents

Composição farmacêutica com glicosaminoglicanos e sua utilização no tratamento das úlceras crónicas Download PDF

Info

Publication number
PT2308497E
PT2308497E PT97725931T PT09772593T PT2308497E PT 2308497 E PT2308497 E PT 2308497E PT 97725931 T PT97725931 T PT 97725931T PT 09772593 T PT09772593 T PT 09772593T PT 2308497 E PT2308497 E PT 2308497E
Authority
PT
Portugal
Prior art keywords
glycosaminoglycans
treatment
pharmaceutical composition
chronic ulcers
ulcers
Prior art date
Application number
PT97725931T
Other languages
English (en)
Inventor
Iván López-Belmonte Encina
María De Los Angeles Canales Mayordomo
Elena Cebadera Miranda
Original Assignee
Rovi Lab Farmaceut Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rovi Lab Farmaceut Sa filed Critical Rovi Lab Farmaceut Sa
Publication of PT2308497E publication Critical patent/PT2308497E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97725931T 2008-07-01 2009-06-30 Composição farmacêutica com glicosaminoglicanos e sua utilização no tratamento das úlceras crónicas PT2308497E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200802002A ES2340902B1 (es) 2008-07-01 2008-07-01 Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.

Publications (1)

Publication Number Publication Date
PT2308497E true PT2308497E (pt) 2014-07-24

Family

ID=41319881

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97725931T PT2308497E (pt) 2008-07-01 2009-06-30 Composição farmacêutica com glicosaminoglicanos e sua utilização no tratamento das úlceras crónicas

Country Status (15)

Country Link
US (2) US20110201572A1 (pt)
EP (1) EP2308497B1 (pt)
JP (1) JP2011526608A (pt)
CN (1) CN102176915A (pt)
AU (1) AU2009265623B2 (pt)
BR (1) BRPI0913839A2 (pt)
CA (1) CA2766483C (pt)
CY (1) CY1115780T1 (pt)
DK (1) DK2308497T3 (pt)
ES (2) ES2340902B1 (pt)
MX (1) MX2010014552A (pt)
PL (1) PL2308497T3 (pt)
PT (1) PT2308497E (pt)
RU (1) RU2011103459A (pt)
WO (3) WO2010000905A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2357601B1 (es) * 2011-01-26 2012-03-21 Laboratorios Farmacéuticos Rovi, S.A. Procedimiento de preparación de derivados de glicosaminoglicanos donadores de óxido n�?trico y su uso en tratamiento de úlceras crónicas.
JP2012245943A (ja) * 2011-05-31 2012-12-13 Hitachi Automotive Systems Ltd 制御装置
JP5942133B2 (ja) * 2012-09-11 2016-06-29 学校法人関西文理総合学園 蛍光プローブ及びこれを用いた酵素活性検出方法
KR20170123345A (ko) * 2015-03-20 2017-11-07 오르후스 우니베르시테트 지질단백질 대사 장애의 치료를 위한 pcsk9의 억제제
EP3273239A1 (en) 2016-07-19 2018-01-24 Laboratorios Farmacéuticos Rovi, S.A. Procedure of analysis of glycosaminoglycans, heparins and their derivatives by nuclear magnetic resonance
TWI698241B (zh) * 2017-09-05 2020-07-11 國立成功大學 用於治療缺血的肝素組合物
ES2792298B2 (es) * 2020-04-27 2022-04-20 Farm Rovi Lab Sa Procedimiento para la obtencion de heparinas de bajo peso molecular y heparinas de bajo peso molecular obtenidas por el mismo

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004A (en) * 1849-01-09 chinnqck
FR2400036A1 (fr) * 1977-08-08 1979-03-09 Choay Sa Heparines purifiees et leur preparation
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
IT1245907B (it) * 1991-05-17 1994-10-25 Alfa Wassermann Spa Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
EP1033375A4 (en) * 1997-11-20 2002-04-24 Ikuo Yamashina MODIFICATION OF LOW MOLECULAR MASS HEPARIN AND REMEDY FOR SKIN Ulcer
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
AU2002309473A1 (en) 2001-01-08 2002-10-08 Human Genome Sciences, Inc. Keratinocyte growth factor-2
HK1077740A1 (en) 2001-12-20 2006-02-24 Ct Ingenieria Genetica Biotech Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation
EP1499317A1 (en) 2002-05-02 2005-01-26 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
US20060040896A1 (en) * 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
CU23388B6 (es) 2006-01-31 2009-07-16 Ct Ingenieria Genetica Biotech Composición farmacéutica de microesferas para prevenir la amputación del pie diabético

Also Published As

Publication number Publication date
US20140066402A1 (en) 2014-03-06
BRPI0913839A2 (pt) 2015-10-20
CN102176915A (zh) 2011-09-07
ES2340902A1 (es) 2010-06-10
AU2009265623B2 (en) 2014-11-20
JP2011526608A (ja) 2011-10-13
WO2010000905A1 (es) 2010-01-07
CY1115780T1 (el) 2017-01-25
PL2308497T3 (pl) 2014-10-31
DK2308497T3 (da) 2014-07-14
WO2010000906A1 (es) 2010-01-07
ES2476966T3 (es) 2014-07-15
WO2010000904A1 (es) 2010-01-07
CA2766483C (en) 2017-01-17
ES2340902B1 (es) 2011-05-03
EP2308497A1 (en) 2011-04-13
EP2308497B1 (en) 2014-04-16
CA2766483A1 (en) 2010-01-07
RU2011103459A (ru) 2012-08-10
AU2009265623A1 (en) 2010-01-07
US9211305B2 (en) 2015-12-15
MX2010014552A (es) 2011-04-26
US20110201572A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
WO2008106102A9 (en) Inhibitors of rtp801 and their use in disease treatment
IL206080A0 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
EP2079526A4 (en) COMPOSITIONS AND ITS USES IN THE TREATMENT OF WOUNDS
HK1209053A1 (zh) 地來西坦在慢性疼痛的治療中的用途
PL2308497T3 (pl) Kompozycja farmaceutyczna zawierająca glikozoaminoglikany oraz jej zastosowanie w leczeniu przewlekłych owrzodzeń
AU2008303948A8 (en) Use of the peptide Asn-Asp-Asp-Cys-Glu- Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu alone or in combination with the peptide Thr-Thr-Ser-Gln-Val- Arg-Pro-Arg as a therapeutic agent
IL212672A (en) Cycloandesdepsipeptide compounds and their use in drug production
HK1160471A1 (en) Aminophosphinic derivatives that can be used in the treatment of pain
GB0921803D0 (en) Drug composition and its use in therapy
IL207965A0 (en) N-substitutedbenzenepropanamide ofr denzenepropenamide derivatives for use in the treatment of pain and inflammation
GB2459076B (en) Improvements in and relating to medical devices
IL219768A0 (en) Drug combination with thebromine and its use in therapy
IL207647A0 (en) Use of interleukin-1 conjugates in the treatment of diabetes
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
IL219769A0 (en) Drug combination with theromine and its use in therapy
GB0921805D0 (en) Drug composition and its use in therapy
GB0910375D0 (en) Drug composition and its use in therapy
EP2440211A4 (en) USE OF TELOCINOBUFAGIN AS ANALGESIC IN THE TREATMENT OF ACUTE AND CHRONIC PAIN, PHARMACEUTICAL COMPOSITION CONTAINING TELOCINOBUFAGIN AND USE THEREOF
LT2699545T (lt) Nauji amino-pirolino dariniai ir jų naudojimas metabolinio sindromo prevencijai ir (arba) gydymui
GB0918727D0 (en) Drug composition and its use in therapy
GB0909354D0 (en) Drug composition and its use in therapy
GB0919890D0 (en) Drug composition and its use in therapy
GB0921804D0 (en) Drug composition and its use in therapy
GB0918728D0 (en) Drug composition and its use in therapy
GB0909352D0 (en) Drug composition and its use in therapy